Blue Owl Capital Holdings »

Artiva Biotherapeutics shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Artiva Biotherapeutics (ARTV) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Artiva Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Artiva Biotherapeutics held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Artiva Biotherapeutics by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2026-06-30 $8.5M 875k 9.70

More positions owned by Blue Owl Capital Holdings

Space Exploration Techn Corp Class A Com Stk (SPCX)
Aktis Oncology (AKTS)
Cullinan Oncology (CGEM)
Larimar Therapeutics (LRMR)
Nuveen Churchill Direct Lend Com Shs (NCDL)
Maplight Therapeutics (MPLT)
Capital One Financial (COF)
Owl Rock Capital Corporation (OBDC)
Deep Fission Ord
Dell Technologies CL C (DELL)
Holley (HLLY)
Eyepoint Com New (EYPT)
Sagimet Biosciences Com Ser A (SGMT)
Corvus Pharmaceuticals (CRVS)
Artiva Biotherapeutics (ARTV)

View all positions for Blue Owl Capital Holdings

Top funds holding Artiva Biotherapeutics

RA Capital Management
5AM Venture Management
VR Adviser
Blue Owl Capital Holdings
venBio Partners
Franklin Resources
Revelation Capital Management
BlackRock
Vanguard Capital Management
Wellington Management Company
Propel Bio Management
Millennium Management
Two Sigma Investments
Geode Capital Management
Simplify Asset Management

View all funds holding Artiva Biotherapeutics